Browsing by Author "Escalante Canto, Paul"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Displasia Torácica Asfixiante o Síndrome de Jeune
    (Universidad de Cuenca, 2017-12) Sempértegui Cárdenas, Pablo; Escalante Canto, Paul; Maestre Calderón, Manolo Patricio
    Jeune Syndrome is a rare skeletal dystrophy, characterized by short ribs and alterations in limbs and pelvis. The respiratory distress is determined by the degree of thoracic stricture, and later, pancreatic or renal insufficiency may occur. A case of a 7-months-old infant who came to the Vicente Corral Moscoso Hospital for pneumonia without treatment response in the cantonal hospital was presented. When the patient arrives he presents a respiratory insufficiency and it calls the attention a cylindrical thorax, markedly narrow and elongated in addition of micromelia and polydactyly. A respiratory support and antibiotics were given during hospitalization having a favorable evolution.
  • Thumbnail Image
    Item
    Eficacia de racecadotrilo en el tratamiento de la enfermedad diarreica aguda, en niños de 3 a 36 meses, en el servicio de emergencia del Hospital Vicente Corral Moscoso. Ensayo clínico controlado ciego. 2014.
    (Universidad de Cuenca, 2018-11) Morales García, Johnny Xavier; Escalante Canto, Paul; Ojeda Orellana, Marco Ribelino; Sempértegui Cárdenas, Pablo Xavier
    Objective: To determine the efficacy of the combined treatment of oral rehydration salts (ORS) and racecadotril against the use of ORS and placebo in children aged between 3 and 36 months with acute diarrhea disease (ADD), in the Vicente Corral Moscoso Hospital (VCMH) emergency service. Method: It is a blind controlled clinical trial in children from 3 to 36 months of the VCMH emergency service, with acute diarrheic disease, without dehydration or mild or moderate dehydration; they do not need hospitalization, without previous antidiarrheal treatment or antibiotic, if their parents or legal representatives sign the informed consent. A total of 79 patients were recruited, 45 in the ORS plus racecadotril group and 34 ORS plus placebo group. Results: The groups were clinically comparable, the patients in the ORS plus racecadotril group showed a significant difference in the number of diarrheas per day from 48 hours [2.7 (DS: ± 1.5), the ORS plus placebo group 4.1 (DS: ± 2.6)] with a p: 0.012; at 72 hours, the racecadotril group [2.2 (DS: ± 1.7), and placebo group [3.3 (DS: ± 2.5)] with p: 0.027. No significant difference was found in the first 24 hours (p: 0.27). Conclusions: Racecadotril is an effective medication to reduce the number of diarrhea after 48 hours, in the initial treatment of children with ADD accompanying ORS therapy in a group of patients treated at the Vicente Corral Moscoso Hospital.